2Yap TM,Camm AJ. Drug induced QT prolongation and torsade de pointes[J]. Heart,2003,89(11):1 367.
3Haverkamp W,Breithardt G,Camm AJ,et al . The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications [J]. European Heart Journal,2000,21:1 216.
4Shaffer D,Singer S,Korvick J,et al. Concominant risk factors in reports of torsade de pointes associated with macrolide use: Review of theunited states Food and Drug Administration Adverse Event Reporting System[J]. Clin Infect Dis. 2002,35:197.
5Brandriss MW,Richardson WS,Barold SS. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsade de pointes): case report and review[J]. Clin Infect Dis,1994,18(6):995.
6Kundu S, Williams SR, Nordt SP, et al. Clarithromycin-induced ventricular tachycardia [J]. Ann Emerg Med,1997,30(4):542.
7Promphan W,Khongphatthanathin A, Horchaiprasit K, et al. Roxithromycin induced torsade de pointes in a patient with complex congenital heart disease and complete atrioventricular block[J]. Pacing Clin Electrophysiol,2003,26(6):1424.
